SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XILLIX FDA APPROVED
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Edward W. Richmond who wrote (437)7/19/1999 11:02:00 AM
From: Garry K.  Read Replies (2) of 572
 
Like many other Xillix shareholders, I feel Olympus is at total control of the helm....they seem to move at their own pace and have their own objectives. Perhaps if Olympus wants control of Xillix's technology, they should pay for it in the form of a takeover. Pay the Xillix shareholder a fair price for the stock, and they can do whatever they want with the technology -- incorporate it into their own product lines, develop the second generation products themselves, or shelve it.

Any comments out there?

Garry
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News